Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Prescription Drug Sales Up Just 4 Percent In 2007 – IMS Health Report

This article was originally published in The Pink Sheet Daily

Executive Summary

Generic competition, safety issues and Medicare Part D are factors in decline to 3.8 percent growth from 8 percent in 2006.

You may also be interested in...



Cancer Drugs Become Top Selling Therapeutic Category In The World

Lipid-lowering drugs remain top category in U.S., despite lower sales.

Cancer Drugs Become Top Selling Therapeutic Category In The World

Lipid-lowering drugs remain top category in U.S., despite lower sales.

Mylan Launches Generic Norvasc; 180-Day Exclusivity May Be Moot

Pfizer counters by launching an “authorized” generic under its Greenstone brand.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS067397

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel